Indo Amines Ltd
Incorporated in 1992, Indo Amines Limited is a global manufacturer and supplier of Fine & Specialty chemicals.[1]
- Market Cap ₹ 812 Cr.
- Current Price ₹ 112
- High / Low ₹ 176 / 81.9
- Stock P/E 11.5
- Book Value ₹ 49.6
- Dividend Yield 0.46 %
- ROCE 18.3 %
- ROE 19.0 %
- Face Value ₹ 5.00
Pros
- Company has delivered good profit growth of 34.0% CAGR over last 5 years
Cons
- Promoter holding has decreased over last 3 years: -9.93%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 221 | 234 | 253 | 285 | 355 | 528 | 479 | 541 | 786 | 945 | 943 | 1,079 | 1,127 | |
| 202 | 212 | 222 | 249 | 314 | 473 | 437 | 479 | 734 | 858 | 863 | 977 | 1,014 | |
| Operating Profit | 18 | 22 | 30 | 36 | 41 | 55 | 42 | 61 | 52 | 87 | 80 | 101 | 113 |
| OPM % | 8% | 10% | 12% | 13% | 12% | 10% | 9% | 11% | 7% | 9% | 8% | 9% | 10% |
| 1 | 1 | 1 | 3 | 4 | 7 | 7 | 8 | 10 | 4 | 16 | 15 | 23 | |
| Interest | 4 | 5 | 4 | 4 | 8 | 10 | 11 | 9 | 14 | 17 | 22 | 22 | 24 |
| Depreciation | 6 | 10 | 12 | 12 | 12 | 15 | 20 | 11 | 14 | 17 | 15 | 17 | 20 |
| Profit before tax | 9 | 8 | 15 | 23 | 25 | 38 | 18 | 49 | 35 | 57 | 58 | 77 | 93 |
| Tax % | 36% | 35% | 38% | 29% | 36% | 34% | 30% | 23% | 33% | 28% | 26% | 27% | |
| 6 | 5 | 9 | 16 | 16 | 25 | 13 | 37 | 23 | 41 | 43 | 56 | 71 | |
| EPS in Rs | 0.93 | 0.80 | 1.38 | 2.46 | 2.40 | 3.78 | 1.92 | 5.31 | 3.23 | 5.72 | 6.05 | 7.61 | 9.73 |
| Dividend Payout % | 27% | 31% | 36% | 21% | 21% | 13% | 26% | 10% | 15% | 9% | 8% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 18% |
| 3 Years: | 11% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 34% |
| 3 Years: | 34% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | 8% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| Last Year: | 19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31 | 33 | 33 | 33 | 33 | 33 | 33 | 35 | 35 | 35 | 36 | 36 | 36 |
| Reserves | 10 | 12 | 17 | 36 | 48 | 92 | 102 | 127 | 152 | 190 | 228 | 281 | 324 |
| 54 | 51 | 50 | 62 | 91 | 131 | 143 | 159 | 207 | 232 | 217 | 284 | 307 | |
| 62 | 60 | 67 | 81 | 75 | 90 | 83 | 131 | 160 | 140 | 153 | 177 | 176 | |
| Total Liabilities | 156 | 155 | 167 | 213 | 246 | 346 | 362 | 453 | 554 | 597 | 635 | 779 | 843 |
| 34 | 53 | 51 | 64 | 70 | 116 | 117 | 125 | 182 | 198 | 209 | 265 | 268 | |
| CWIP | 12 | 1 | 0 | 2 | 5 | 8 | 24 | 54 | 22 | 20 | 23 | 35 | 65 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 3 |
| 110 | 102 | 115 | 147 | 171 | 222 | 221 | 274 | 350 | 379 | 401 | 476 | 507 | |
| Total Assets | 156 | 155 | 167 | 213 | 246 | 346 | 362 | 453 | 554 | 597 | 635 | 779 | 843 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19 | 23 | 19 | 15 | 8 | 27 | 39 | 56 | 15 | 20 | 70 | 35 | |
| -21 | -14 | -10 | -23 | -21 | -43 | -36 | -50 | -39 | -30 | -27 | -82 | |
| 2 | -9 | -9 | 7 | 16 | 17 | -3 | -1 | 32 | 4 | -41 | 42 | |
| Net Cash Flow | 0 | 1 | 0 | -1 | 3 | 2 | 0 | 5 | 9 | -5 | 2 | -5 |
| Free Cash Flow | 0 | 6 | 9 | -2 | -14 | -16 | 2 | 6 | -24 | -10 | 44 | -48 |
| CFO/OP | 121% | 123% | 82% | 58% | 47% | 74% | 107% | 107% | 44% | 34% | 101% | 52% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 83 | 62 | 66 | 78 | 76 | 78 | 73 | 89 | 78 | 72 | 84 | 86 |
| Inventory Days | 55 | 59 | 60 | 66 | 84 | 68 | 98 | 96 | 86 | 78 | 65 | 73 |
| Days Payable | 87 | 68 | 66 | 80 | 101 | 80 | 80 | 113 | 88 | 60 | 68 | 67 |
| Cash Conversion Cycle | 51 | 52 | 60 | 64 | 59 | 66 | 91 | 71 | 76 | 91 | 82 | 93 |
| Working Capital Days | -10 | -12 | 6 | -38 | 9 | 5 | 10 | 9 | 1 | 17 | 27 | 28 |
| ROCE % | 15% | 14% | 19% | 23% | 22% | 22% | 11% | 19% | 14% | 17% | 17% | 18% |
Insights
In beta| Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Number of Employees Count |
|
||||
| Installed Capacity MTPA |
|||||
| Inventory Period Days |
|||||
| Receivables Period Days |
|||||
| Gross Current Assets Days |
|||||
| Number of Countries Exported To Count |
|||||
Documents
Announcements
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Apr
-
Announcement Under Regulation 30 (LODR) - Update
30 Mar - Indo Amines stake in Indo Speciality diluted from 51.39% to 39.39%; reclassified as associate effective 30-Mar-2026.
- Closure of Trading Window 27 Mar
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
8 Feb - Newspaper Publication of Unaudited Financial Results for the quarter ended 31st December, 2025
- Financial Results For The Quarter And Nine Months Ended 31St December, 2025 7 Feb
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Aug 2021TranscriptAI SummaryPPT
-
Jun 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Nov 2018TranscriptPPT
Business Overview:[1][2][3]
IAL is engaged in the chemical intermediates business with a product
basket of 70+ products. It is a manufacturer, developer, and supplier of:
a) Fine Chemicals
b) Speciality Chemicals
c) Performance Chemicals
d) Perfumery Chemicals
e) Active Pharmaceutical Ingredients